Article
Antithrombin Cambridge II(A384S) mutation frequency and antithrombin activity levels in 120 of deep venous thrombosis and 150 of cerebral infarction patients in a single center in Southern China.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis - 1 Sept 2010
Zhang Guang-sen, Tang Yang-ming, Tang Mei-qing, Qing Zi-Ju, Shu Chang, Tang Xiang-qi, Deng Ming-yang, Tan Li-ming
Abstract excerpt
Antithrombin Cambridge II(A384S) mutation shows a relatively high frequency in western population. Some studies suggest that the mutation is an independent genetic risk factor both for deep vein thrombosis (DVT) and for arterial thrombosis, but whether the mutation has racial difference or has a general significance for thrombophilia remains unclear. In this study we performed an analysis of the prevalence of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.